Increase of CIK cell efficacy by upregulating cell surface MICA and inhibition of NKG2D ligand shedding in multiple myeloma

Increased effect of IMiDs by addition of cytokine-induced killer cells in multiple myeloma

(2015) Katharina F. Bullok et al.   HEMATOLOGICAL ONCOLOGY

Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC)

(2014) Leonard Christopher Schmeel et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Enhancing cytokine-induced killer cell therapy of multiple myeloma

(2013) Chunsheng Liu et al.   EXPERIMENTAL HEMATOLOGY

Role of NKG2D in cytokine-induced killer cells against multiple myeloma cells

(2012) Xuzhang Lu et al.   CANCER BIOLOGY & THERAPY

Expression of MICA, MICB and NKG2D in human leukemic myelomonocytic and cervical cancer cells

(2011) Benny Weiss-Steider et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Modulation of NKG2D-ligand Cell Surface Expression Enhances Immune Cell Therapy of Cancer

(2011) Baocheng Huang et al.   JOURNAL OF IMMUNOTHERAPY

Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)

(2010) C. Hontscha et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis

(2009) Cai Zhang et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

NKG2D ligands: key targets of the immune response

(2008) Segundo González et al.   TRENDS IN IMMUNOLOGY